Literature DB >> 2407580

Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.

M K Hostetter1.   

Abstract

The hyperglycemic patient remains persistently at risk for infectious complications. Whether ascribable to diabetes mellitus, to the administration of glucocorticoids, or to the infusion of hyperalimentation fluids, hyperglycemia may impair several mechanisms of humoral host defense, including such varied neutrophil functions as adhesion, chemotaxis, and phagocytosis. In addition, binding of glucose to the biochemically active site of the third component of complement C3 inhibits the attachment of this protein to the microbial surface and thereby impairs opsonization. Last, several pathogens frequently encountered in hyperglycemic patients possess unique mechanisms of virulence that flourish in the hyperglycemic environment. Most notable in this regard is the yeast Candida albicans, which expresses a glucose-inducible protein that is structurally and functionally homologous to a complement receptor on mammalian phagocytes. This protein promotes adhesion in the yeast and subverts phagocytosis by the host. Thus, hyperglycemia serves as a central mechanism in the predisposition of hyperglycemic patients to infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407580     DOI: 10.2337/diab.39.3.271

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  51 in total

1.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes.

Authors:  M Noritake; Y Katsura; N Shinomiya; M Kanatani; Y Uwabe; N Nagata; S Tsuru
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 3.  Diabetes mellitus and burns. Part I-basic science and implications for management.

Authors:  Ioannis Goutos; Rebecca Spenser Nicholas; Atisha A Pandya; Sudip J Ghosh
Journal:  Int J Burns Trauma       Date:  2015-03-20

Review 4.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 5.  Glycemic control in the medical intensive care unit.

Authors:  Michelle A Kovalaske; Gunjan Y Gandhi
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 6.  Inpatient diabetology. The new frontier.

Authors:  Nicolas N Abourizk; Chaula K Vora; Parveen K Verma
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

7.  Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice.

Authors:  Y Kannan; M Tokunaga; M Moriyama; H Kinoshita; Y Nakamura
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.

Authors:  A Sahu; T R Kozel; M K Pangburn
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

9.  Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation.

Authors:  T-M Lin; W-j Chen; H-Y Chen; P-W Wang; H-L Eng
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 10.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.